-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

2466 Metagenomics Next-Generation Sequencing for Identifying Pathogens in Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Program: Oral and Poster Abstracts
Session: 803. Emerging Diagnostic Tools and Techniques: Poster II
Hematology Disease Topics & Pathways:
Technology and Procedures, Clinically relevant, NGS
Sunday, December 6, 2020, 7:00 AM-3:30 PM

Wenjun Liu1*, Zhiping Fan, MD2*, Fen Huang2*, Na Xu2*, Hui Liu2*, Li Xuan, MD2*, Zhixiang Wang2*, Jun Xu3*, Pengcheng Shi4*, Jing Sun, MD2, Qifa Liu, MD2 and Ren Lin, MD2*

1Department of hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3Department of hematology,Nanfang Hospital, Southern Medical University, Guangzhou, China
4Nanfang Hospital, Southern Medical University, Guangzhou, China


Objective: Central nervous system (CNS) infections are severe neurological complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical usefulness of metagenomic next-generation sequencing (mNGS) remains underdiscussion in diagnosis of CNS infections after allo-HSCT. We conducted a prospective study to compare mNGS and conventional testing in investigating the pathogens of CNS infections in allo-HSCT recipients.

Methods: Patients with CNS manifestations accompanying with viruses associated diseases or viremia and patients with unexplainable CNS manifestations were enrolled in this study. Pathogens detected by mNGS only were further confirmed by validated testing.

Results: Of 53 patients enrolled in this study, 36 episodes of CNS infections were diagnosed in 35 patients including 35 clinical and microbiologic confirmed infections and 1 clinical confirmed infection.Among these 36 episodes, mNGS identified 5 that were not identified by conventional testing and 4 of the 5 obtained a clinical effect with adjusting treatments. Among the remaining 31 infections, metagenomic NGS made concurrent diagnoses with conventional testing in 30 and 1 diagnosed without etiological evidence both by conventinal testing and mNGS. Viruses were the most common pathogens with EBV(12/34) was the most frequent, followed by HHV-6(9/34), HSV-1(4/34), CMV(3/34), adenovirus(3/34), VZV(2/34), HHV-7(1/34). The 2-year cumulative incidence of overall CNS infections and CNS viral infections post-transplantation were 7.4±0.01% and 6.2%±0.01%, respectively.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH